Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Aug 21:20:130-7.
doi: 10.12659/MSMBR.891064.

Effects of YC-1 on learning and memory functions of aged rats

Affiliations

Effects of YC-1 on learning and memory functions of aged rats

Ipek Komsuoglu Celikyurt et al. Med Sci Monit Basic Res. .

Abstract

Background: The aim of this study was to investigate the effects of a potent nitric oxide-guanylate cyclase activator, 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole (YC-1), on learning and memory functions in aged rats.

Material and methods: Rats were divided into 2 groups as 4-month-old and 24-month-old rats. Rats received YC-1 (1 mg/kg/day) for 2 weeks long-term. Morris water maze (MWM) and passive avoidance (PA) tests were used to determine learning and memory functions.

Results: In the MWM test, there is a significant increase in the acquisition latency (1-4 days) of 24-month-old rats. There is a significant reduction in the "time spent in the escape platform's quadrant" in 24-month-old rats compared to 4-month-old rats in the probe trial of the MWM test. YC-1 treatment reversed the reduction of the "time spent in the escape platform's quadrant" of 24-month-old rats. In the PA test, there was no significant difference in the 1st-day latency of rats in all groups. On the 2nd day, retention latency significantly decreased in the 24-month-old rats compared to 4-month-olds. YC-1 reversed the diminished retention latency in 24-month-old rats. YC-1 treatment and aging did not affect results of the locomotor activity test or the foot-shock sensitivity test, suggesting our results were not due to a change in motor activity or disability of the animals.

Conclusions: Our findings suggest that activation of the NO-sGC-cGMP pathway plays an important role in spatial and emotional learning and memory functions in aged rats.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Latency (s) to find the platform of 4-month-old, DMSO-4-month-old, 24-month-old, DMSO-24-month-old, and 24-month-old+YC-1 rats in the MWM test. ## There is a significant reduction in the latency of 4-month-old rats (1-way ANOVA, Day 1 vs. Day 4, p: 0.0023 F(3,36)=5.838). *, **, *** 24-month-old rats had an increase in their acquisition latency compared to 4-month-old rats (p<0.05, p<0.01, p<0.01 and p<0.001) and 24-month-old rats treated with YC-1 (p<0.05, p<0.01, p<0.01 and p<0.01).
Figure 2
Figure 2
Time spent in the escape platform quadrant (s) of 4-month-old, DMSO-4-month-old, 24-month-old, DMSO-24-month-old, and YC-1+24-month-old groups in probe trial of MWM test. *** Retention latency of 24-month-old aged rats was significantly shortened compared to 4-month-old young (p<0.0001, Dunnett’s test) and YC-1-treated 24-month-old group (p<0.0001, Dunnett’s test).
Figure 3
Figure 3
First-day latency of 4-month-old, DMSO-4-month-old, 24-month-old, DMSO-24-month-old, and YC-1+24-month-old rats in the PA test.
Figure 4
Figure 4
Retention latency (s) of 4-month-old, DMSO-4-month-old, 24-month-old, DMSO-24-month-old, and YC-1+24-month-old rats in the PA test. *** Retention latency of 24-month-old aged rats was significantly shortened compared to 4-month-old (p<0.0001, Dunnett’s test) and YC-1-treated 24-month-old rats (p<0.0001, Dunnett’s test).
Figure 5
Figure 5
Locomotor activity of 4-month-old, DMSO-4-month-old, 24-month-old, DMSO-24-month-old, and YC-1+24-month-old rats.
Figure 6
Figure 6
Foot-shock sensitivity of 4-month-old, DMSO, 24-month-old, and 24-month-old+YC-1 rats.

Similar articles

Cited by

References

    1. Moffat SD. Aging and spatial navigation: What do we know and where do we go? Neuropsychol Rev. 2009;19(4):478–89. - PubMed
    1. Mattson MP, Duan W, Chan SL, et al. Neuroprotective and neurorestorative signal transduction mechanisms in brain aging: modification by genes, diet and behavior. Neurobiol Aging. 2002;23(5):695–705. - PubMed
    1. Schliebs R, Arendt T. The significance of the cholinergic system in the brain during aging and in Alzheimer’s disease. J Neural Transm. 2006;113(11):1625–44. - PubMed
    1. Vanguilder HD, Bixler GV, Sonntag WE, Freeman WM. Hippocampal expression of myelin-associated inhibitors is induced with age-related cognitive decline and correlates with deficits of spatial learning and memory. J Neurochem. 2012;121(1):77–98. - PMC - PubMed
    1. Prast H, Philippu A. Nitric oxide as modulator of neuronal function. Prog Neurobiol. 2001;64(1):51–68. - PubMed

Publication types

Substances